First Tracks Biotherapeutics Inc (TRAX) Balance Sheet Statement

Screener

	Q1 '26	Q4 '25	Q1 '25
Cash and cash equivalents	$248.47M—	$238.2M—	——
Short-term investments	$37.99M—	$73.44M—	——
Total current assets	$289.4M—	$316.4M—	——
Property and equipment, net	$1.17M—	$1.37M—	——
Total assets	$290.58M—	$330.55M—	——
Accounts payable	$7.5M—	$3.11M—	——
Total current liabilities	$33.11M—	$31.02M—	——
Total stockholders' equity	$257.46M-28.0%	$287.49M-26.6%	$357.72M—
Total liabilities and stockholders' equity	$290.58M—	$330.55M—	——

First Tracks Biotherapeutics Inc TRAX Balance Sheet Statement